Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Status:
Withdrawn
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The investigators are attempting to determine a less invasive method of treatment for
postdural puncture headaches that can occur after regional anesthesia. The investigators will
be evaluating the relief of headache with those subjects receiving treatment with a
sphenopalatine ganglion block with bupivacaine versus placebo, evaluating the incidence of
epidural blood patch, pain score of headache at 1 hour, then 24, 48, and 72 hours lower with
post study treatment versus placebo, and potential side effects of those patients receiving
study therapy as well as epidural blood patch.